Carbamazepine Extended-Release Capsules: A Retrospective Review of Its Use in Children and Adolescents

Annals of Clinical Psychiatry ◽

10.1080/10401230600653304 ◽

2006 ◽

Vol 18 (1) ◽

pp. 3-7 ◽

Author(s):

Lawrence Ginsberg

Keyword(s):

Children And Adolescents ◽

Retrospective Review ◽

Extended Release

Download Full-text

Guanfacine extended release for children and adolescents with attention-deficit/hyperactivity disorder: efficacy following prior stimulant treatment

10.26226/morressier.5785edd1d462b80296c9a2a5 ◽

2016 ◽

Author(s):

Jiri Prochazka

Keyword(s):

Attention Deficit Hyperactivity Disorder ◽

Children And Adolescents ◽

Attention Deficit ◽

Extended Release ◽

Stimulant Treatment ◽

Hyperactivity Disorder

Download Full-text

Evaluating the Likelihood to be Helped or Harmed after Treatment with Viloxazine Extended‐Release in Children and Adolescents with Attention Deficit/Hyperactivity Disorder

International Journal of Clinical Practice ◽

10.1111/ijcp.14330 ◽

2021 ◽

Author(s):

Azmi Nasser ◽

Alisa R. Kosheleff ◽

Joseph T. Hull ◽

Tesfaye Liranso ◽

Peibing Qin ◽

...

Keyword(s):

Attention Deficit Hyperactivity Disorder ◽

Children And Adolescents ◽

Attention Deficit ◽

Extended Release ◽

Hyperactivity Disorder

Download Full-text

4.54 A RETROSPECTIVE REVIEW OF CLOZAPINE USE IN CHILDREN AND ADOLESCENTS

Journal of the American Academy of Child & Adolescent Psychiatry ◽

10.1016/j.jaac.2019.08.294 ◽

2019 ◽

Vol 58 (10) ◽

pp. S237

Author(s):

Ardelle L.D. Komaryk ◽

Dean Elbe ◽

Leah Burgess

Keyword(s):

Children And Adolescents ◽

Retrospective Review

Download Full-text

Quetiapine extended release versus aripiprazole in children and adolescents with first-episode psychosis: the multicentre, double-blind, randomised tolerability and efficacy of antipsychotics (TEA) trial

The Lancet Psychiatry ◽

10.1016/s2215-0366(17)30166-9 ◽

2017 ◽

Vol 4 (8) ◽

pp. 605-618 ◽

Author(s):

Anne Katrine Pagsberg ◽

Pia Jeppesen ◽

Dea Gowers Klauber ◽

Karsten Gjessing Jensen ◽

Ditte Rudå ◽

...

Keyword(s):

Children And Adolescents ◽

Extended Release ◽

First Episode Psychosis ◽

First Episode ◽

Double Blind ◽

Episode Psychosis

Download Full-text

Efficacy and Safety of Extended-Release Venlafaxine in the Treatment of Generalized Anxiety Disorder in Children and Adolescents: Two Placebo-Controlled Trials

American Journal of Psychiatry ◽

10.1176/ajp.2007.164.2.290 ◽

2007 ◽

Vol 164 (2) ◽

pp. 290-300 ◽

Author(s):

Moira A. Rynn ◽

Mark A. Riddle ◽

Paul P. Yeung ◽

Nadia R. Kunz

Keyword(s):

Anxiety Disorder ◽

Children And Adolescents ◽

Generalized Anxiety Disorder ◽

Extended Release ◽

Generalized Anxiety ◽

Controlled Trials ◽

Efficacy And Safety

Download Full-text

PIH23 Cost-Effectiveness of Guanfacine Extended Release as an Adjunctive Therapy to a Psychostimulant Compared to Psychostimulant Monotherapy for the Treatment of Attention Deficit/Hyperactivity Disorder in Children and Adolescents

Value in Health ◽

10.1016/j.jval.2011.08.927 ◽

2011 ◽

Vol 14 (7) ◽

pp. A401-A402 ◽

Author(s):

V. Sikirica ◽

M. Erder ◽

J. Xie ◽

D. Macaulay ◽

M. Diener ◽

...

Keyword(s):

Attention Deficit Hyperactivity Disorder ◽

Cost Effectiveness ◽

Children And Adolescents ◽

Attention Deficit ◽

Adjunctive Therapy ◽

Extended Release ◽

Hyperactivity Disorder

Download Full-text

Evaluation of the current data on guanfacine extended release for the treatment of ADHD in children and adolescents

Expert Opinion on Pharmacotherapy ◽

10.1080/14656566.2019.1706480 ◽

2020 ◽

Vol 21 (4) ◽

pp. 417-426

Author(s):

Ann Childress ◽

Asmara Hoo-Cardiel ◽

Peter Lang

Keyword(s):

Children And Adolescents ◽

Extended Release ◽

Download Full-text

Comparative Efficacy of Guanfacine Extended Release Versus Atomoxetine for the Treatment of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents: Applying Matching-Adjusted Indirect Comparison Methodology

CNS Drugs ◽

10.1007/s40263-013-0102-x ◽

2013 ◽

Vol 27 (11) ◽

pp. 943-953 ◽

Author(s):

Vanja Sikirica ◽

Robert L. Findling ◽

James Signorovitch ◽

M. Haim Erder ◽

Ryan Dammerman ◽

...

Keyword(s):

Attention Deficit Hyperactivity Disorder ◽

Children And Adolescents ◽

Attention Deficit ◽

Extended Release ◽

Indirect Comparison ◽

Comparative Efficacy ◽

Hyperactivity Disorder ◽

Adjusted Indirect Comparison

Download Full-text

A Double-Blind, Randomized, Placebo-Controlled Trial of Divalproex Extended-Release in the Treatment of Bipolar Disorder in Children and Adolescents

Journal of the American Academy of Child & Adolescent Psychiatry ◽

10.1097/chi.0b013e31819c55ec ◽

2009 ◽

Vol 48 (5) ◽

pp. 519-532 ◽

Author(s):

Karen Dineen Wagner ◽

Laura Redden ◽

Robert A. Kowatch ◽

Timothy E. Wilens ◽

Scott Segal ◽

...

Keyword(s):

Bipolar Disorder ◽

Children And Adolescents ◽

Extended Release ◽

Controlled Trial ◽

Download Full-text

Development of Guanfacine Extended-Release Dosing Strategies in Children and Adolescents with ADHD Using a Physiologically Based Pharmacokinetic Model to Predict Drug–Drug Interactions with Moderate CYP3A4 Inhibitors or Inducers

Pediatric Drugs ◽

10.1007/s40272-017-0270-0 ◽

2017 ◽

Vol 20 (2) ◽

pp. 181-194 ◽

Author(s):

Aiqun Li ◽

Karen Yeo ◽

Devin Welty ◽

Haojing Rong

Keyword(s):

Drug Interactions ◽

Children And Adolescents ◽

Extended Release ◽

Pharmacokinetic Model ◽

Physiologically Based Pharmacokinetic Model ◽

Physiologically Based Pharmacokinetic ◽

Physiologically Based ◽

Dosing Strategies ◽

Cyp3a4 Inhibitors

Download Full-text